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Morphea, or localized scleroderma, is an inflammatory disease that leads to sclerosis of the skin and underlying 
tissues due to excessive collagen deposition. Oral involvement is unusual and it may produce white linear fibrotic 
areas with a scar-like appearance, atrophy of tongue papillae, gingival recession and alveolar bone resorption. We 
report a case of a 13-year-old girl who consulted for progressive recession on the attached gingiva of her upper left 
incisors. She also presented a hypopigmented line on the left side skin of her upper lip, which continued through the 
vermilion and the lip mucosa, including the gingiva of the affected teeth. Clinical examination, blood tests, com-
puterized axial tomography, echo-Doppler ultrasound and histopathological evaluation confirmed the diagnosis 
of morphea. Treatment with methotrexate and systemic corticosteroids was conducted. After 24 months, no other 
lesions appeared. No adverse side effects have been reported so far.




Morphea, or localized scleroderma, is an inflamma-
tory disease that leads to sclerosis of the skin and un-
derlying tissues due to excessive collagen deposition. It 
differs from systemic scleroderma due to the absence of 
Raynaud’s phenomenon and the compromise of organs 
such as the heart, lung, kidneys and gastrointestinal sys-
tem (1,2). Its incidence ranges from 0.4 to 2.7 cases per 
100,000 individuals/year, and is more common in Cau-
casian women, with a female:male ratio of 2.4-4.2:1. 
The classification of the Pediatric Rheumatology Euro-
pean Society (3) recognizes five main types of which 
linear scleroderma is presented as a unilateral lesion that 
affects the extremities, face or scalp. In mild cases, only 
a linear area of ivory-colored pigmentation can be obser-
ved on the surface of the skin; however, deeper compro-
mise may affect the subcutaneous tissue, bone and even 
the central nervous system (1,3). 
The etiopathogenesis of morphea remains unclear, but 
it is thought to be due to a combination of genetic pre-
disposition, which generates an autoimmune response 
triggered by factors such as trauma, radiation, drugs 
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and infections (1,2). The vascular abnormalities are the 
result of the artery wall thickening, which reduces the 
lumen and alters vascularization in the area. Vascular 
dysfunction is one of the earliest changes observed, and 
may represent the initial event in the pathogenesis of the 
disease (1,2) 
The basis for the diagnosis of morphea is a histopatholo-
gical assessment (1,4,5), which can vary in appearance 
depending on whether the injury is at an early or late 
stage (2). At the beginning of the disease, a perivascular 
lymphocytic infiltrate is observed with few plasma cells 
and eosinophils in the reticular dermis. Endothelial cells 
may be swollen and the collagen fibers thicker. During 
the more advanced stages of morphea, the inflammatory 
infiltrate disappears, and the collagen fibers become 
thicker, eosinophilic and huddled together. This increa-
se in collagen is at the expense of the number of blood 
vessels and the size of the lumen (2,6). Morphea patients 
may present positive ANA autoantibodies in their blood. 
Antibody titers do not seem to be related to the course or 
severity of the disease (2,7,8).
To date, few cases of linear scleroderma with intraoral 
involvement have been reported (1,4,5,9). Below, we 
present the case of a 13-year-old girl diagnosed with 
severe intraoral linear scleroderma with involvement of 
the gingiva and underlying alveolar bone, besides a brief 
review of the literature.
Case Report
A 13-year-old girl was referred to the diagnosis service 
of the Faculty of Dentistry of Universidad Andres Bello, 
Viña del Mar, Chile, because of increased mobility of her 
upper front incisors and the occurrence of a white spot 
on her upper lip. She previously attended a private clinic 
Fig. 1. A) White hypopigmented line in the skin and vermilion of the upper lip. B) Com-
mitment of the attached gingiva related to the upper left central and lateral incisors. C)
Labial mucosa involvement. D) Appearance of the skin and vermilion of the upper lip 
after 2 years of treatment.
where they performed root canal treatments on the upper 
left lateral and central incisors. She reported no systemic 
diseases and no family history of similar diseases.
Clinical examination showed a hypopigmented white 
line on the skin of the left side of the upper lip, which 
continued through the vermilion and the lip mucosa, in-
cluding the gingiva in relation to the upper left lateral and 
central incisors. Both teeth had a small gingival reces-
sion (Fig. 1 A-C), increased mobility and were slightly 
intruded, causing an anterior open bite. X-rays revealed 
advanced vertical alveolar bone loss (Fig. 2 A,B), while 
buccopalatal sections of computerized axial tomography 
(CAT) showed loss of the buccal alveolar ridge of both 
teeth. Linear white lesions of ≈1cm were also present on 
the dorsal and ventral surfaces of the tongue. An incisio-
nal biopsy of the affected labial mucosa was performed. 
Histopathological analysis of the area showed a marked 
thickening of collagen in the lamina propia, associated 
with a perivascular lymphomonocytic infiltrate and a 
strong presence of eosinophils. (Fig. 3 A,B). 
The blood analysis, including a complete blood count, 
biochemical profile and serum levels of complement C3 
and C4 were found normal. ENA, ANA and ANCA anti-
bodies were negative. Echo-Doppler ultrasound showed 
the left facial and labial artery lumen diameters to be di-
minished by 50% compared with the right side arteries.
The patient was diagnosed with localized scleroderma 
(morphea). In collaboration with rheumatology consul-
tants, an initial treatment of prednisone 15 mg/day, me-
thotrexate (MTX) 20 mg/week (intramuscular) and folic 
acid 5 mg daily after the dose of MTX was given. The 
patient reported no adverse side effects.
The drug therapy described above was maintained for 
15 months. No other lesions appeared during this period 
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Fig. 2. A) Occlusal Radiograph. B) Periapical radiograph with advanced vertical al-
veolar bone loss.
Fig. 3. Histopathological findings. A) Biopsy of the labial mucosa 
under a light microscope, in which marked fibrosis of the lamina pro-
pria is observed, with hyalinization of collagen and a lymphocytic 
infiltrate with a perivascular and periductal distribution (hematox-
ylin-eosin staining, 4x). B) Higher magnification of an area with a 
perivascular mononuclear infiltrate (hematoxylin-eosin staining, 
40x). 
and the existing ones underwent no change or became 
smaller (Fig. 1D). The patient is currently (before the 
submission of this case) on a regular dose of MTX 2.5 
mg/week, and 5mg/day of folic acid on the methotrexa-
te-free days. No adverse side effects have been reported 
so far.
Discussion
Localized scleroderma, is an inflammatory disease that 
primarily affects the skin and underlying tissues, leading 
to sclerosis of the affected tissues. Besides the genetic 
predisposition, there are environmental triggers (trau-
matic factors, radiation, medications and infections) 
(1,2). The disease may have an autoimmune basis due to 
the presence of positive ANA autoantibodies in 20-80% 
of patients (6). It usually affects young women between 
4 -20-years-old, with a wide range of clinical presenta-
tions (5).
The typical presentation of morphea corresponds to a 
single linear injury with unilateral distribution that com-
monly affects the extremities, face and/or parietal region 
of the scalp (1,3,4), showing a linear zone of alopecia, 
with indurated skin and a shiny ivory color. It may or 
may not distort the underlying bone. Fortunately, in our 
case, the patient did no develop scalp lesions. The le-
sions may extend to the cheek, nose and/or upper lip, 
causing deformities or asymmetries of the facial struc-
tures or altering the implantation tissue of the teeth (3). 
Nevertheless, oral involvement in morphea is an uncom-
mon feature. To our knowledge, there are only 20 ca-
ses reporting oral involvement (1,3-5,9). When the oral 
tissues are affected, it seems to have a predilection for 
the labial mucosa and upper anterior teeth as well as the 
soft palate and tongue. The most typical lesion is a white 
patch or a fibrotic area affecting the labial mucosa and/or 
gingiva causing gingival recession, loss of alveolar bone 
and tooth mobility (5). Van der Veken et al., (1) reported 
a case of a 19-year-old women with morphea showing a 
pale linear lesion extending from her nose to her upper 
lip on the right-hand side of her face, with a progressive 
recession of the gingiva between the central and lateral 
incisors of the same side. The clinical features of this 
case are very similar to ours, but differ in the extension 
of the skin lesions and bone loss. In our case, the skin 
involvement was minimal and the bone loss was severe, 
while in this case, the cutaneous compromised was quite 
severe, but the bone involvement was just limited to a 
widening of the periodontal ligament on the mesial side 
of the central incisors. 
Pace et al., (4) reported in 2010 a case of frontal linear 
scleroderma with intraoral involvement. Althought the 
compromise of the skin was much more aggressive in 
this case, the intraoral involvement had some similira-
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ties with ours. Similar to the present report, the authors 
reported the presence of a fibrotic lesion extending onto 
the attached gingiva, associated with a mobile upper 
right central incisor together with marked gingival re-
cession on the mesial aspect of the lateral incisor. 
Tang et al., (5) reported the case of a 20-year-old female 
with a progressive recession of the gingiva around the 
premolars and molars on her left maxilla and a white 
plaque over the left upper vestibular mucosa and hard 
palate. The affected teeth showed bone resorption and 
a widened periodonal ligament. Histopathological fea-
tures showed hialynization of subepithelial collagen 
and the presence of perivascular lymphocytic infiltrates. 
This characteristics are very similar to the ones present 
in our case.
Clinical, radiological and histopathological features of 
other reports of oral involvement in lineal scleroderma 
are very similar to the ones present in our case (1,3-5). 
Some differences could be seen regarding the extension 
of the gingival and alveolar bone compromise, proba-
bly attributed to the progression stage at the moment the 
diagnosis was made.
The main differential diagnoses for localized morphea is 
general morphea. General morphea presents with white 
lesions affecting two different anatomical regions. In the 
present case the lesions only affected the orofacial re-
gion. Because of the vasculitis observed in the histopa-
thological analysis, Wegener´s granulomatosis has to be 
ruled out. In the present report, the patient had negative 
ANCA antibodies and exhibit no clinical feature sugges-
tive of Wegener´s granulomatosis.
There is still no standardized and effective treatment 
for linear scleroderma. Today, the most commonly used 
and accepted drugs for treatment are MTX and systemic 
glucocorticoids, used together most of the time (3,7,10-
14). Zulian et al. concluded that long-term MTX therapy 
stops the progression of the disease and improves the 
appearance of clinical manifestations. Our patient took 
low doses of prednisone for 15 months, which was wi-
thdrawn stepwise, then maintained to date (two years 
after the start of treatment) only with oral MTX. With 
treatment, the progression of the disease stopped and the 
white line on the lip became slightly less noticeable (Fig. 
1D). Currently, the patient has not reported discomfort or 
adverse side effects to the drug therapy. The discrepan-
cies in the management of reported cases may occur due 
to the fact that there are no standardized measurement 
instruments to compare the progress of patients before, 
during and after treatment, leading to great variability in 
the results of the reported studies in the literature. Fina-
lly, there are an insufficient number of controlled pros-
pective studies that certify and evaluate the effectiveness 
of methotrexate (with or without corticosteroids) in the 
long term. The goal of the treatment was to stop progres-
sion of the morphea lesions.
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